Balgopal Commercial confirmed that for the quarter ended June 30, 2026, there was no deviation in how it utilized the 10.52 Cr raised through a preferential issue of shares and warrants. The funds were specifically earmarked for investments in similar business activities, meeting long-term funding requirements, working capital, and general corporate purposes to support the company’s future growth plans. All raised funds were deployed exactly as originally intended, highlighting the company's adherence to its financial commitments for capital deployment.